- CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
-
Zhang G, Luo X, Zhang W, Chen E, Xu J, Wang F, Cao G, Ju Z, Jin D, Huang X, Zhou W, Song Z
- KMID: 2500346
- Cancer Res Treat.
- 2020 Apr;52(2):622-633.
- doi: 10.4143/crt.2019.593
Purpose 5-Fluorouracil (5-Fu) is used as a conventional chemotherapy drug in chemotherapy for patients with advanced colorectal cancer, but many patients still suffer from treatment failure due to 5-Fu resistance. Emerging observations revealed... -
- CITED
-
- Close
- SHARE
-
- Close
- Extended Whole‑body Ga‑68 DOTATATE PET‑CT in evaluating Tumour‑Induced Osteomalacia: Case report and review of literature
-
Tan T, Chen E, Chew M, Chye P, Wong M
- KMID: 2516691
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):130-135.
- doi: 10.1007/s13139-021-00695-6
Tumour-induced osteomalacia is a rare paraneoplastic syndrome that manifests as chronic hypophosphataemia, non-specific bone pain and muscle weakness. It is generally caused by phosphaturic mesenchymal tumour (PMT), which is uncommonly... -
- CITED
-
- Close
- SHARE
-
- Close
- Demographic and Clinical Correlates of Seizure Frequency: Findings from the Managing Epilepsy Well Network Database
-
Chen E, Sajatovic , Liu H, Bukach A, Tatsuoka C, Welter E, Schmidt SS, Bamps YA, Stoll SC, Spruill TM, Friedman D, Begley CE, Shegog R, Fraser RT, Johnson EK, Jobst BC
- KMID: 2407948
- J Clin Neurol.
- 2018 Apr;14(2):206-211.
- doi: 10.3988/jcn.2018.14.2.206
BACKGROUND AND PURPOSE: Epilepsy is a chronic neurological disease that represents a tremendous burden on both patients and society in general. Studies have addressed how demographic variables, socioeconomic variables, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients
-
Hou J, Gane E, Balabanska R, Zhang W, Zhang J, Lim TH, Xie Q, Yeh CT, Yang SS, Liang X, Komolmit P, Leerapun A, Xue Z, Chen E, Zhang Y, Xie Q, Chang TT, Hu TH, Lim SG, Chuang WL, Leggett B, Bo Q, Zhou X, Triyatni M, Zhang W, Yuen MF
- KMID: 2554426
- Clin Mol Hepatol.
- 2024 Apr;30(2):191-205.
- doi: 10.3350/cmh.2023.0422
Background/Aims: Four-week treatment of linvencorvir (RO7049389) was generally safe and well tolerated, and showed anti-viral activity in chronic hepatitis B (CHB) patients. This study evaluated the efficacy, safety, and pharmacokinetics... -
- CITED
-
- Close
- SHARE
-
- Close
